Improvement of endothelial function in patients with hypertension and type 2 diabetes after treatment with telmisartan-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Improvement of endothelial function in patients with hypertension and type 2 diabetes after treatment with telmisartan

Published:2010-06-17 Issue:8 Volume:33 Page:796-801
ISSN:0916-9636
Container-title:Hypertension Research
language:en
Short-container-title:Hypertens Res

Author:

Wago Takehiko,Yoshimoto Takanobu,Akaza Itaru,Tsuchiya Kyoichiro,Izumiyama Hajime,Doi Masaru,Hirata Yukio

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Link

http://www.nature.com/articles/hr2010107.pdf

Reference41 articles.

1. Deanfield JE, Halcox JP, Rabelink TJ . Endothelial function and dysfunction: testing and clinical relevance. Circulation 2007; 115: 1285–1295.

2. Gokce N, Keaney Jr JF, Hunter LM, Watkins MT, Nedeljkovic ZS, Menzoian JO, Vita JA . Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol 2003; 41: 1769–1775.

3. Mancini GB, Henry GC, Macaya C, O’Neill BJ, Pucillo AL, Carere RG, Wargovich TJ, Mudra H, Luscher TF, Klibaner MI, Haber HE, Uprichard AC, Pepine CJ, Pitt B . Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation 1996; 94: 258–265.

4. Treasure CB, Klein JL, Weintraub WS, Talley JD, Stillabower ME, Kosinski AS, Zhang J, Boccuzzi SJ, Cedarholm JC, Alexander RW . Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 1995; 332: 481–487.

5. Cooper SA, Whaley-Connell A, Habibi J, Wei Y, Lastra G, Manrique C, Stas S, Sowers JR . Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance. Am J Physiol Heart Circ Physiol 2007; 293: H2009–H2023.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Markers of Vascular Dysfunction in Hypertension;Current Medicinal Chemistry;2024-07-25

2. Effects of telmisartan on metabolic syndrome components: a comprehensive review;Biomedicine & Pharmacotherapy;2024-02

3. Peroxisome proliferator-activated receptors, farnesoid X receptor, and dual modulating drugs in hypertension;Frontiers in Physiology;2023-06-23

4. Treatment Reducing Endothelial Activation Protects against Experimental Cerebral Malaria;Pathogens;2022-06-02

5. Telmisartan use and risk of dementia in type 2 diabetes patients with hypertension: A population-based cohort study;PLOS Medicine;2021-07-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3